This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Lubrizol LifeSciences is a healthcare solution partner for medical device manufacturers who need product development support and drug eluting device solutions. LifeSciences, along with Vesta and Particle Sciences, is positioned as the only healthcare product solution partner offering polymer customization, complex drug formulation and contract manufacturing solutions.
Vesta offers custom contract manufacturing services, including precision silicone and thermoplastic extrusion as well as comprehensive silicone fabrication. With decades of experience, the company's service, engineering expertise and commitment to quality are sought by customers worldwide. Vesta's combined team works together to care for the life of customer products.
"We have significantly enhanced our capabilities through the combination of strong polymer technology, application know-how and world-class component manufacturing," states Deb Langer, vice president and general manager, Lubrizol LifeSciences. "As healthcare companies look for total solution providers, we continue to focus on the right areas in order to provide valuable offerings to our customers."
To show their commitment to the medical device market, LifeSciences is investing more than $15 million to expand its global development and manufacturing facilities, positioning Lubrizol to better serve the growing market for medical device development and contract manufacturing. This capital investment will expand multiple facilities and increase Lubrizol LifeSciences' inhouse engineering capacity for both silicone and thermoplastic products. Part of this investment expands Vesta's thermoplastic capabilities to include: tip forming, tube flaring, pad printing, hole punching/drilling, precision cutting, reflow, braided tubing lamination and more.
"When customers partner with Lubrizol LifeSciences, they benefit from working with us at every stage in their development process," states Robert Miller, global business director, medical devices. "With a long history of polymer expertise and significant investment, Lubrizol LifeSciences is positioned to offer full-service development for next generation medical and pharmaceutical innovations."
